Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Pharmacoepidemiology"" wg kryterium: Temat


Tytuł :
Analytical approaches to minimizing immeasurable time bias in cohort studies.
Autorzy :
Oh IS; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.
Baek YH; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.
Jeong HE; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.
Filion KB; Department of Medicine, McGill University, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.
Shin JY; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.; Samsung Advanced Institute for Health Sciences and Technology, Seoul, South Korea.
Pokaż więcej
Źródło :
International journal of epidemiology [Int J Epidemiol] 2021 Jul 09; Vol. 50 (3), pp. 987-999.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Heart Failure*/drug therapy
Heart Failure*/epidemiology
Pharmacoepidemiology*
Adrenergic beta-Antagonists ; Bias ; Cohort Studies ; Humans ; Proportional Hazards Models
Czasopismo naukowe
Tytuł :
A new likelihood model for analyses of pharmacoepidemiologic case-control studies which avoids decision rules for determining latent exposure status.
Autorzy :
Støvring H; Biostatistics, Department of Public Health, Aarhus University, Bartholins Allé 2, 8000, Aarhus C, Denmark. .; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark. .
Pottegård A; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Hallas J; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło :
BMC medical research methodology [BMC Med Res Methodol] 2021 Jul 08; Vol. 21 (1), pp. 144. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmacoepidemiology*
Case-Control Studies ; Databases, Factual ; Humans ; Likelihood Functions ; Logistic Models
Czasopismo naukowe
Tytuł :
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects.
Autorzy :
Pariente A; University Bordeaux, Inserm, BPH, U1219, Team Pharmacoepidemiology, 33000 Bordeaux, France; CHU de Bordeaux, pôle de santé publique, service de pharmacologie médicale, unité de pharmaco-épidémiologie et bon usage du médicament, 33000 Bordeaux, France. Electronic address: .
Bezin J; University Bordeaux, Inserm, BPH, U1219, Team Pharmacoepidemiology, 33000 Bordeaux, France; CHU de Bordeaux, pôle de santé publique, service de pharmacologie médicale, unité de pharmaco-épidémiologie et bon usage du médicament, 33000 Bordeaux, France.
Pokaż więcej
Źródło :
Therapie [Therapie] 2021 Jul-Aug; Vol. 76 (4), pp. 305-309. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Immunization Programs*
Pharmacoepidemiology*
COVID-19/*epidemiology
COVID-19/*prevention & control
COVID-19/immunology ; Europe/epidemiology ; Humans ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza Vaccines/adverse effects ; Influenza Vaccines/immunology ; SARS-CoV-2/immunology
Czasopismo naukowe
Tytuł :
Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety.
Autorzy :
Duszynski KM; Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
Stark JH; Vaccine Medical, Scientific and Clinical Affairs, Pfizer Inc., New York, New York, USA.
Cohet C; Vaccines Clinical Research & Development, GlaxoSmithKline, Wavre, Belgium.
Huang WT; Office of Preventive Medicine, Taiwan Centers for Disease Control, Taipei, Taiwan.
Shin JY; School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
Lai EC; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Man KKC; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong.
Choi NK; Department of Health Convergence, Ewha Womans University, Seoul, South Korea.
Khromava A; Epidemiology and Benefit Risk, Sanofi Pasteur Ltd., Toronto, Ontario, Canada.
Kimura T; Astellas Pharma Inc., Northbrook, Illinois, USA.
Huang K; Global Medical Epidemiology, Worldwide Medical and Safety, Pfizer Inc., New York, New York, United States of America.
Watcharathanakij S; Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Kochhar S; Global Healthcare Consulting, New Delhi, India.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Chen RT; Brighton Collaboration, The Task Force for Global Health, Decatur, Georgia, USA.
Pratt NL; Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2021 Jul; Vol. 30 (7), pp. 843-857. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Information Interoperability*
COVID-19/*prevention & control
COVID-19 Vaccines/*adverse effects
Pharmacoepidemiology/*methods
Product Surveillance, Postmarketing/*methods
Asia/epidemiology ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; Databases, Factual/statistics & numerical data ; Electronic Health Records/statistics & numerical data ; Geography ; Humans ; International Cooperation ; Pacific Islands/epidemiology ; Pharmacoepidemiology/organization & administration ; Pharmacovigilance ; Product Surveillance, Postmarketing/statistics & numerical data ; SARS-CoV-2/immunology
Czasopismo naukowe
Tytuł :
Choppy waters: The importance of accounting for shifting drug utilization during the COVID-19 pandemic in future observational drug-related studies.
Autorzy :
Shakeri A; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
Gomes T; Unity Health Toronto, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Suda K; Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.; Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Tadrous M; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2021 May; Vol. 128 (5), pp. 649-651. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/drug therapy
COVID-19*/epidemiology
Chronic Disease*/drug therapy
Chronic Disease*/epidemiology
Drug Utilization*/statistics & numerical data
Drug Utilization*/trends
Pharmaceutical Preparations*/classification
Pharmaceutical Preparations*/supply & distribution
Pharmacoepidemiology*/methods
Pharmacoepidemiology*/trends
Strategic Stockpile*/methods
Strategic Stockpile*/statistics & numerical data
Canada/epidemiology ; Drug-Related Side Effects and Adverse Reactions/prevention & control ; Forecasting ; Humans ; Medication Adherence/statistics & numerical data ; Practice Patterns, Physicians' ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
Autorzy :
Strich JR; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.; US Public Health Service Commissioned Corps, Rockville, Maryland, USA.
Ricotta E; Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Warner S; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Lai YL; Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Demirkale CY; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Hohmann SF; Vizient, Irving, Texas, USA.
Rhee C; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Klompas M; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Palmore T; Hospital Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Powers JH; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, National Cancer Institute Campus at Frederick, Frederick, Maryland, USA.
Dekker JP; Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Adjemian J; US Public Health Service Commissioned Corps, Rockville, Maryland, USA.; Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Matsouaka R; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.; Program of Comparative Effectiveness Methodology, Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA.
Woods CW; School of Medicine, Duke University, Durham, North Carolina, USA.
Danner RL; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Kadri SS; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Feb 16; Vol. 72 (4), pp. 611-621.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Drug Resistance, Multiple, Bacterial*
Pharmacoepidemiology*
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Azabicyclo Compounds/pharmacology ; Azabicyclo Compounds/therapeutic use ; Ceftazidime/pharmacology ; Ceftazidime/therapeutic use ; Drug Combinations ; Hospitals ; Humans ; Microbial Sensitivity Tests ; Retrospective Studies ; beta-Lactamases
Czasopismo naukowe
Tytuł :
On the Causal Interpretation of Rate-Change Methods: The Prior Event Rate Ratio and Rate Difference.
Autorzy :
van Aalst R
Thommes E
Postma M
Chit A
Dahabreh IJ
Pokaż więcej
Źródło :
American journal of epidemiology [Am J Epidemiol] 2021 Jan 04; Vol. 190 (1), pp. 142-149.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Causality*
Models, Statistical*
Pharmacoepidemiology*
Research Design*
Pneumonia/*chemically induced
Proton Pump Inhibitors/*administration & dosage
Case-Control Studies ; Humans ; United Kingdom
Czasopismo naukowe
Tytuł :
Approaches to Optimize Medication Data Analysis in Clinical Cohort Studies.
Autorzy :
Duprey MS; Department of Pharmacy and Health Systems Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Devlin JW; Department of Pharmacy and Health Systems Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Briesacher BA; Department of Pharmacy and Health Systems Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Travison TG; Aging Brain Center, Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Griffith JL; Department of Health Sciences, Bouve College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Inouye SK; Aging Brain Center, Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of the American Geriatrics Society [J Am Geriatr Soc] 2020 Dec; Vol. 68 (12), pp. 2921-2926. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Analgesics, Opioid*/standards
Analgesics, Opioid*/therapeutic use
Data Analysis*
Medication Reconciliation*/classification
Medication Reconciliation*/standards
Pharmacoepidemiology*
Research Design*
Analgesics/*therapeutic use
Aged ; Elective Surgical Procedures ; Female ; Humans ; Male ; Prospective Studies ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Pharmacoepidemiology of medications omitted in New Zealand Residential Aged Care Homes.
Autorzy :
Garratt SM; Health Systems, School of Population Health, The University of Auckland, Auckland, New Zealand.; National Ageing Research Institute, Melbourne, Victoria, Australia.
Kerse NM; General Practice and Primary Care, School of Population Health, The University of Auckland, Auckland, New Zealand.
Peri K; School of Nursing, The University of Auckland, Auckland, New Zealand.
Jonas MF; Health Systems, School of Population Health, The University of Auckland, Auckland, New Zealand.
Scahil SL; School of Pharmacy, The University of Auckland, Auckland, New Zealand.
Pokaż więcej
Źródło :
Australasian journal on ageing [Australas J Ageing] 2020 Dec; Vol. 39 (4), pp. e490-e497. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmaceutical Preparations*
Pharmacoepidemiology*
Aged ; Homes for the Aged ; Humans ; New Zealand/epidemiology ; Nursing Homes ; Psychotropic Drugs/adverse effects
Czasopismo naukowe
Tytuł :
CPT: Pharmacometrics & Systems Pharmacology – Inception, Maturation, and Future Vision.
Autorzy :
Rowland Yeo, Karen (AUTHOR)
Hennig, Stefanie (AUTHOR)
Krishnaswami, Sriram (AUTHOR)
Strydom, Natasha (AUTHOR)
Ayyar, Vivaswath S. (AUTHOR)
French, Jonathan (AUTHOR)
Sinha, Vikram (AUTHOR)
Sobie, Eric (AUTHOR)
Zhao, Ping (AUTHOR)
Friberg, Lena E. (AUTHOR)
Mentré, France (AUTHOR)
Pokaż więcej
Źródło :
CPT: Pharmacometrics & Systems Pharmacology. Jul2021, Vol. 10 Issue 7, p649-657. 9p.
Czasopismo naukowe
Tytuł :
Opioids and the Risk of Fracture: A Self-Controlled Case Series Study in the Clinical Practice Research Datalink.
Autorzy :
Peach EJ
Pearce FA
Gibson J
Cooper AJ
Chen LC
Knaggs RD
Pokaż więcej
Źródło :
American journal of epidemiology [Am J Epidemiol] 2021 Jul 01; Vol. 190 (7), pp. 1324-1331.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Analgesics, Opioid/*adverse effects
Fractures, Bone/*epidemiology
Case-Control Studies ; Female ; Fractures, Bone/chemically induced ; Humans ; Incidence ; Male ; Middle Aged ; Pharmacoepidemiology ; Practice Patterns, Physicians'/statistics & numerical data ; Risk Factors ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project.
Autorzy :
Thurin NH; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France.; INSERM U1219, Université de Bordeaux, Bordeaux, France.
Lassalle R; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France.
Schuemie M; Epidemiology Analytics, Janssen Research and Development, Titusville, New Jersey, USA.; Observational Health Data Sciences and Informatics (OHDSI), New York, New York, USA.
Pénichon M; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France.
Gagne JJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Rassen JA; Aetion, Inc., New York, New York, USA.
Benichou J; Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France.; INSERM U1181, Paris, France.
Weill A; Caisse Nationale de l'Assurance Maladie, Paris, France.
Blin P; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France.
Moore N; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France.; INSERM U1219, Université de Bordeaux, Bordeaux, France.; CHU de Bordeaux, Bordeaux, France.
Droz-Perroteau C; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Sep; Vol. 29 (9), pp. 993-1000. Date of Electronic Publication: 2020 Mar 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Pharmacovigilance*
Adverse Drug Reaction Reporting Systems/*statistics & numerical data
Databases, Factual/*statistics & numerical data
National Health Programs/*statistics & numerical data
Pharmacoepidemiology/*methods
Acute Kidney Injury/chemically induced ; Acute Kidney Injury/epidemiology ; Adverse Drug Reaction Reporting Systems/organization & administration ; Chemical and Drug Induced Liver Injury/epidemiology ; Chemical and Drug Induced Liver Injury/etiology ; Data Mining/methods ; France/epidemiology ; Gastrointestinal Hemorrhage/chemically induced ; Gastrointestinal Hemorrhage/epidemiology ; Humans ; Myocardial Infarction/chemically induced ; Myocardial Infarction/epidemiology ; Pharmacoepidemiology/statistics & numerical data
Czasopismo naukowe
Tytuł :
Using nationally representative survey data for external adjustment of unmeasured confounders: An example using the NHANES data.
Autorzy :
Hernández-Díaz S; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Bateman BT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Palmsten K; HealthPartners Institute, Minneapolis, Minnesota.
Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Huybrechts KF; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Sep; Vol. 29 (9), pp. 1151-1158. Date of Electronic Publication: 2019 Dec 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Confounding Factors, Epidemiologic*
Databases, Factual/*statistics & numerical data
Nutrition Surveys/*statistics & numerical data
Pharmacoepidemiology/*methods
Prescription Drugs/*adverse effects
Antidepressive Agents/adverse effects ; Depression/drug therapy ; Drug Prescriptions/statistics & numerical data ; Female ; Heart Defects, Congenital/chemically induced ; Heart Defects, Congenital/epidemiology ; Humans ; Life Style ; Obesity/epidemiology ; Patient Acceptance of Health Care/statistics & numerical data ; Pharmacoepidemiology/statistics & numerical data ; Pregnancy ; Pregnancy Complications/drug therapy ; Prevalence ; Probability ; Risk Factors ; Serotonin and Noradrenaline Reuptake Inhibitors/adverse effects ; Smoking/epidemiology ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Quality of reporting of drug exposure in pharmacoepidemiological studies.
Autorzy :
Hempenius M; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Luijken K; Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands.
de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Klungel O; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
Groenwold R; Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Department of Clinical Pharmacy, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Sep; Vol. 29 (9), pp. 1141-1150. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Reproducibility of Results*
Observational Studies as Topic/*standards
Pharmacoepidemiology/*standards
Research Design/*standards
Drug Therapy/statistics & numerical data ; Guidelines as Topic ; Humans ; Observational Studies as Topic/statistics & numerical data ; Pharmacoepidemiology/statistics & numerical data ; Research Design/statistics & numerical data
Czasopismo naukowe
Tytuł :
Tuberculosis drug safety and pharmacovigilance in health system of Kosova: A cross-sectional analysis.
Autorzy :
Krasniqi S; Institute of Pharmacology and Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Prishtina 'Hasan Prishtina', Prishtina, Kosovo.
Neziri B; Institute of Clinical Physiology, Faculty of Medicine, University of Prishtina 'Hasan Prishtina', Prishtina, Kosovo.
Jakupi A; Health Agency for Development - HAD, Prishtina, Kosovo.
Shurdhaj I; Health Agency for Development - HAD, Prishtina, Kosovo.
Daci A; Department of Pharmacy, Faculty of Medicine, University of Prishtina 'Hasan Prishtina', Prishtina, Kosovo.
Jupolli-Krasniqi N; Health Agency for Development - HAD, Prishtina, Kosovo.
Pira M; Health Agency for Development - HAD, Prishtina, Kosovo.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Sep; Vol. 29 (9), pp. 1037-1045. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antitubercular Agents/*adverse effects
Central Nervous System Diseases/*epidemiology
Gastrointestinal Diseases/*epidemiology
Pharmacoepidemiology/*organization & administration
Tuberculosis, Pulmonary/*drug therapy
Adolescent ; Adult ; Age Factors ; Central Nervous System Diseases/chemically induced ; Cross-Sectional Studies ; Female ; Follow-Up Studies ; Gastrointestinal Diseases/chemically induced ; Humans ; Incidence ; Kosovo/epidemiology ; Male ; Middle Aged ; National Health Programs/organization & administration ; National Health Programs/statistics & numerical data ; Pharmacoepidemiology/statistics & numerical data ; Pharmacovigilance ; Registries/statistics & numerical data ; Risk Factors ; Sex Factors ; Surveys and Questionnaires/statistics & numerical data ; Young Adult
Czasopismo naukowe
Tytuł :
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic.
Autorzy :
Pottegård A; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Kurz X; Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands.
Moore N; Bordeaux PharmacoEpi, University of Bordeaux, Bordeaux, France.
Christiansen CF; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Klungel O; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Aug; Vol. 29 (8), pp. 825-831. Date of Electronic Publication: 2020 May 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Research Design*
Coronavirus Infections/*epidemiology
Pharmacoepidemiology/*organization & administration
Pneumonia, Viral/*epidemiology
Betacoronavirus ; COVID-19 ; Data Collection/methods ; Humans ; Pandemics ; Pharmacoepidemiology/standards ; SARS-CoV-2 ; Time Factors
Czasopismo naukowe
Tytuł :
Population-Based Signals of Antidepressant Drug Interactions Associated With Unintentional Traumatic Injury.
Autorzy :
Leonard CE; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Therapeutic Effectiveness Research, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Brensinger CM; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Acton EK; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Miano TA; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Dawwas GK; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Horn JR; Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA.
Chung S; AthenaHealth, Inc., Watertown, Massachusetts, USA.
Bilker WB; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Dublin S; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.; Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
Soprano SE; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pham Nguyen TP; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Manis MM; Department of Pharmacy Practice, McWhorter School of Pharmacy, Samford University, Birmingham, Alabama, USA.
Oslin DW; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Mental Illness Research, Education, and Clinical Center, Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, Pennsylvania, USA.
Wiebe DJ; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Penn Injury Science Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hennessy S; Center for Pharmacoepidemiology Research and Training, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Therapeutic Effectiveness Research, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Aug; Vol. 110 (2), pp. 409-423. Date of Electronic Publication: 2021 Mar 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antidepressive Agents/*adverse effects
Wounds and Injuries/*epidemiology
Adolescent ; Aged ; Aged, 80 and over ; Animals ; Bayes Theorem ; Databases, Factual ; Drug Interactions ; Emergency Medical Services/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Patient Discharge/statistics & numerical data ; Pharmacoepidemiology ; Rats ; Young Adult
Czasopismo naukowe
Tytuł :
A General Propensity Score for Signal Identification Using Tree-Based Scan Statistics.
Autorzy :
Wang SV
Maro JC
Gagne JJ
Patorno E
Kattinakere S
Stojanovic D
Eworuke E
Baro E
Ouellet-Hellstrom R
Nguyen M
Ma Y
Dashevsky I
Cole D
DeLuccia S
Hansbury A
Pestine E
Kulldorff M
Pokaż więcej
Źródło :
American journal of epidemiology [Am J Epidemiol] 2021 Jul 01; Vol. 190 (7), pp. 1424-1433.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Data Interpretation, Statistical*
Propensity Score*
Data Mining/*methods
Drug Evaluation/*statistics & numerical data
Pharmacoepidemiology/*methods
Cohort Studies ; Humans
Czasopismo naukowe
Tytuł :
Brief discussion on sampling variability in 1:1 propensity score matching without replacement.
Autorzy :
Ripollone JE; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Huybrechts KF; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Rothman KJ; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.; Research Triangle Institute, Research Triangle Park, North Carolina, USA.
Ferguson RE; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA.; VA Boston Healthcare System, Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts, USA.
Franklin JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2020 Sep; Vol. 29 (9), pp. 1194-1197. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji :
Journal Article
MeSH Terms :
Data Interpretation, Statistical*
Propensity Score*
Pharmacoepidemiology/*methods
Humans ; Pharmacoepidemiology/statistics & numerical data
Czasopismo naukowe
Tytuł :
Dispensing patterns of emergency medicines prescribed by Australian dentists from 1992 to 2018 - a pharmacoepidemiology study.
Autorzy :
Park JS; International Research Collaborative - Oral Health and Equity, School of Human Sciences, The University of Western Australia, Crawley, WA, Australia.
Kruger E; International Research Collaborative - Oral Health and Equity, School of Human Sciences, The University of Western Australia, Crawley, WA, Australia.
Tennant M; International Research Collaborative - Oral Health and Equity, School of Human Sciences, The University of Western Australia, Crawley, WA, Australia.
Pokaż więcej
Źródło :
International dental journal [Int Dent J] 2020 Aug; Vol. 70 (4), pp. 254-258. Date of Electronic Publication: 2020 Mar 13.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Prescriptions*
Pharmacoepidemiology*
Australia ; Dentists ; Humans ; Professional Role
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies